Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Operating Margin (2021 - 2025)

Historic Operating Margin for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to 23682.56%.

  • Pulse Biosciences' Operating Margin changed N/A to 23682.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 91798.84%, marking a year-over-year change of. This contributed to the annual value of 8293.86% for FY2022, which is 38499900.0% down from last year.
  • Latest data reveals that Pulse Biosciences reported Operating Margin of 23682.56% as of Q3 2025.
  • In the past 5 years, Pulse Biosciences' Operating Margin registered a high of 97166.67% during Q4 2022, and its lowest value of 23682.56% during Q3 2025.
  • Its 3-year average for Operating Margin is 10101.67%, with a median of 3188.45% in 2022.
  • Within the past 5 years, the most significant YoY rise in Pulse Biosciences' Operating Margin was 989925000bps (2022), while the steepest drop was 989925000bps (2022).
  • Over the past 3 years, Pulse Biosciences' Operating Margin (Quarter) stood at 1825.83% in 2021, then skyrocketed by 5422bps to 97166.67% in 2022, then tumbled by -124bps to 23682.56% in 2025.
  • Its last three reported values are 23682.56% in Q3 2025, 97166.67% for Q4 2022, and 4671.33% during Q2 2022.